Emily Leproust

Emily Leproust

Emily Leproust, Ph.D. serves as CEO, co-founder and director of Twist Bioscience. Dr. Leproust is disrupting the process of gene synthesis to enable the exponential growth of synthetic biology applications in multiple fields including medicine, DNA data storage, agricultural biology and industrial chemicals.

In 2015, she was named one of Foreign Policy’s 100 Leading Global Thinkers of 2015 and Fast Company named her one of the most creative people in business.

Prior to Twist Bioscience, she held escalating positions at Agilent Technologies where she architected the successful SureSelect product line that lowered the cost of sequencing and elucidated dozens of Mendelian diseases.